A carregar...

When, why and how tumour clonal diversity predicts survival

Abstract The utility of intratumour heterogeneity as a prognostic biomarker is the subject of ongoing clinical investigation. However, the relationship between this marker and its clinical impact is mediated by an evolutionary process that is not well understood. Here, we employ a spatial computatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Robert Noble, John T. Burley, Cécile Le Sueur, Michael E. Hochberg
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2020-08-01
Colecção:Evolutionary Applications
Assuntos:
Acesso em linha:https://doi.org/10.1111/eva.13057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!